Pink SheetDespite the ongoing upheaval across the agency, the US Food and Drug Administration maintained its typical reliability when it came to meeting user fee goal dates in the first quarter of 2025, the Pi
Pink SheetAnxiety is high as pharmaceutical manufacturers wait to hear from President Trump about whether or not drugs will be included in the next round of tariffs to be announced on 2 April. Trump is expected
ScripIndustry anxiety is riding high as pharmaceutical manufacturers wait to hear from US president Donald Trump about whether or not drugs will be included in the next round of tariffs to be announced on
ScripThe hemophilia market is a challenging and competitive field but Sanofi is confident that fitusiran, which has just been given the green light by the US Food and Drug Administration (28 March), has th